Taierzhuang District People's Hospital
8
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
38%
3 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Registry for the Management of Helicobacter Pylori Infection in Shandong Province
Role: collaborator
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
Role: collaborator
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
Role: collaborator
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
Role: collaborator
Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Role: collaborator
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Role: collaborator
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
Role: collaborator
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
Role: collaborator
All 8 trials loaded